Heidar Arjomand, MD

Platelets and Antiplatelet Therapy in Patients with Diabetes Mellitus

08/01/2008

Both insulin-dependent and non-insulin dependent diabetes mellitus (DM) are powerful and independent risk factors for coronary artery disease (CAD). In patients with diabetes, the risk of CAD is increased two- to four-fold. Atherosclerotic...

Both insulin-dependent and...

08/01/2008

Journal of Invasive Cardiology

Combination Antithrombotic Therapy with Antiplatelet Agents and Anticoagulants for Patients with Atherosclerotic Heart Disease (

08/01/2008

Marc S. Cohen , MD;

Heidar Arjomand , MD;

Michael D. Ezekowitz , MBChB;

ABSTRACT: We reviewed the efficacy and safety of combination antithrombotic therapy with aspirin plus warfarin versus aspirin alone in patients with atherosclerotic heart disease. We performed a comprehensive MEDLINE search of...

ABSTRACT: We reviewed the...

08/01/2008

Journal of Invasive Cardiology

Combination Antithrombotic Therapy with Antiplatelet Agents and Anticoagulants for Patients with Atherosclerotic Heart Disease (

08/01/2008

Marc S. Cohen , MD;

Heidar Arjomand , MD;

Michael D. Ezekowitz , MBChB;

Continued from previous page Potential indications for combination therapy with aspirin plus warfarin Intracardiac thrombi usually form on inflamed or damaged valves, endocardium within an MI, in a dilated or dyskinetic cardiac chamber, or...

Continued from previous...

08/01/2008

Journal of Invasive Cardiology

Case Report

Acute Myocardial Infarction in a Patient with von Willebrand Disease: Pathogenetic Dilemmas and Therapeutic Challenges

08/01/2008

Daniel J. McCormick , DO, FACC;

Heidar Arjomand , MD;

Patrick Aquilina , MD;

Von Willebrand disease (vWD) results from deficiency of von Willebrand factor (vWf), an essential element needed for initial platelet adhesion and subsequent thrombosis.1 The presence of atherosclerotic coronary lesions without occlusive...

Von Willebrand disease (vWD)...

08/01/2008

Journal of Invasive Cardiology